HUM logo

HUM

Humana Inc.

$228.76
+$5.47(+2.45%)
57
Overall
100
Value
16
Tech
55
Quality
Market Cap
$34.12B
Volume
944.32K
52W Range
$206.87 - $315.35
Target Price
$285.50

Company Overview

Mkt Cap$34.12BPrice$228.76
Volume944.32KChange+2.45%
P/E Ratio28.3Open$223.38
Revenue$117.8BPrev Close$223.29
Net Income$1.2B52W Range$206.87 - $315.35
Div Yield3.54%Target$285.50
Overall57Value100
Quality55Technical16

No chart data available

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Sector: Healthcare
Industry: Health Care Plans

Latest News

Benchmark Co. Keeps Their Buy Rating on Humacyte (HUMA)

Benchmark Co. analyst Bruce Jackson maintained a Buy rating on Humacyte yesterday and set a price target of $11.00. The company’s shares closed yes...

TipRanks Auto-Generated Intelligence Newsdesk8 days ago

Humm Group Issues Shares for Employee Incentive Plan

TipRanks Australian Auto-Generated Newsdesk9 days ago

Humm Group Enhances Employee Incentive Plan with New Share Issuance

TipRanks Australian Auto-Generated Newsdesk9 days ago

humm Group Faces Shareholder Dissent at 2025 AGM

TipRanks Australian Auto-Generated Newsdesk10 days ago

Humm Group Evaluates Acquisition Proposal Amidst Shareholder Scrutiny

TipRanks Australian Auto-Generated Newsdesk10 days ago
ABCD
1SymbolPriceChangeVol
2HUM$228.76+2.4%944.32K
3
4
5
6

Get Humana Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.